301 related articles for article (PubMed ID: 11389994)
1. Disease-induced drug targeting using novel peptide-ligand albumins.
Meijer DK; Beljaars L; Molema G; Poelstra K
J Control Release; 2001 May; 72(1-3):157-64. PubMed ID: 11389994
[TBL] [Abstract][Full Text] [Related]
2. Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor.
Beljaars L; Molema G; Schuppan D; Geerts A; De Bleser PJ; Weert B; Meijer DK; Poelstra K
J Biol Chem; 2000 Apr; 275(17):12743-51. PubMed ID: 10777570
[TBL] [Abstract][Full Text] [Related]
3. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
[TBL] [Abstract][Full Text] [Related]
4. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
[TBL] [Abstract][Full Text] [Related]
5. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats.
Adrian JE; Kamps JA; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Terpstra P; Poelstra K
Biochim Biophys Acta; 2007 Jun; 1768(6):1430-9. PubMed ID: 17493581
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
7. The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue.
Beljaars L; Weert B; Geerts A; Meijer DK; Poelstra K
Biochem Pharmacol; 2003 Oct; 66(7):1307-17. PubMed ID: 14505810
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
Beljaars L; Olinga P; Molema G; de Bleser P; Geerts A; Groothuis GM; Meijer DK; Poelstra K
Liver; 2001 Oct; 21(5):320-8. PubMed ID: 11589768
[TBL] [Abstract][Full Text] [Related]
9. Targeting of sugar- and charge-modified albumins to fibrotic rat livers: the accessibility of hepatic cells after chronic bile duct ligation.
Beljaars L; Poelstra K; Molema G; Meijer DK
J Hepatol; 1998 Oct; 29(4):579-88. PubMed ID: 9824267
[TBL] [Abstract][Full Text] [Related]
10. Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.
Hagens WI; Mattos A; Greupink R; de Jager-Krikken A; Reker-Smit C; van Loenen-Weemaes A; Gouw IA; Poelstra K; Beljaars L
Pharm Res; 2007 Mar; 24(3):566-74. PubMed ID: 17245650
[TBL] [Abstract][Full Text] [Related]
11. Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems.
Adrian JE; Poelstra K; Scherphof GL; Molema G; Meijer DK; Reker-Smit C; Morselt HW; Kamps JA
J Hepatol; 2006 Mar; 44(3):560-7. PubMed ID: 16368158
[TBL] [Abstract][Full Text] [Related]
12. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
[TBL] [Abstract][Full Text] [Related]
13. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
[TBL] [Abstract][Full Text] [Related]
14. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
[TBL] [Abstract][Full Text] [Related]
15. Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats.
Du SL; Pan H; Lu WY; Wang J; Wu J; Wang JY
J Pharmacol Exp Ther; 2007 Aug; 322(2):560-8. PubMed ID: 17510318
[TBL] [Abstract][Full Text] [Related]
16. Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers.
Hagens WI; Beljaars L; Mann DA; Wright MC; Julien B; Lotersztajn S; Reker-Smit C; Poelstra K
J Pharmacol Exp Ther; 2008 Mar; 324(3):902-10. PubMed ID: 18077624
[TBL] [Abstract][Full Text] [Related]
17. Targeting dexamethasone to Kupffer cells: effects on liver inflammation and fibrosis in rats.
Melgert BN; Olinga P; Van Der Laan JM; Weert B; Cho J; Schuppan D; Groothuis GM; Meijer DK; Poelstra K
Hepatology; 2001 Oct; 34(4 Pt 1):719-28. PubMed ID: 11584368
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cells.
Melgert BN; Olinga P; Jack VK; Molema G; Meijer DK; Poelstra K
J Hepatol; 2000 Apr; 32(4):603-11. PubMed ID: 10782909
[TBL] [Abstract][Full Text] [Related]
19. The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells.
Li Q; Yan Z; Li F; Lu W; Wang J; Guo C
Nanotechnology; 2012 Jul; 23(26):265101. PubMed ID: 22700686
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of a hepatic stellate cell-targeted doxorubicin construct in bile duct-ligated rats.
Greupink R; Reker-Smit C; Proost JH; van Loenen Weemaes AM; de Hooge M; Poelstra K; Beljaars L
Biochem Pharmacol; 2007 May; 73(9):1455-62. PubMed ID: 17239825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
